Literature DB >> 16957756

Levothyroxine dosage and the limitations of current bioequivalence standards.

James V Hennessey1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16957756     DOI： 10.1038/ncpendmet0273

Source DB:  PubMed          Journal:  Nat Clin Pract Endocrinol Metab        ISSN： 1745-8366


× No keyword cloud information.
  7 in total

1.  An investigation into the influence of experimental conditions on in vitro drug release from immediate-release tablets of levothyroxine sodium and its relation to oral bioavailability.

Authors:  Ivana Kocic; Irena Homsek; Mirjana Dacevic; Jelena Parojcic; Branislava Miljkovic
Journal:  AAPS PharmSciTech       Date:  2011-07-12       Impact factor: 3.246

2.  Healthcare costs associated with switching from brand to generic levothyroxine.

Authors:  Michael Katz; Joseph Scherger; Scott Conard; Leslie Montejano; Stella Chang
Journal:  Am Health Drug Benefits       Date:  2010-03

3.  Timing of levothyroxine administration affects serum thyrotropin concentration.

Authors:  Thien-Giang Bach-Huynh; Bindu Nayak; Jennifer Loh; Steven Soldin; Jacqueline Jonklaas
Journal:  J Clin Endocrinol Metab       Date:  2009-07-07       Impact factor: 5.958

4.  TSH-based protocol, tablet instability, and absorption effects on L-T4 bioequivalence.

Authors:  Marisa Eisenberg; Joseph J Distefano
Journal:  Thyroid       Date:  2009-02       Impact factor: 6.568

Review 5.  Levothyroxine Formulations: Pharmacological and Clinical Implications of Generic Substitution.

Authors:  Salvatore Benvenga; Allan Carlé
Journal:  Adv Ther       Date:  2019-09-04       Impact factor: 3.845

Review 6.  Thyroxine and treatment of hypothyroidism: seven decades of experience.

Authors:  Roselyn Cristelle I Mateo; James V Hennessey
Journal:  Endocrine       Date:  2019-07-18       Impact factor: 3.633

7.  Calculated Parameters of Thyroid Homeostasis: Emerging Tools for Differential Diagnosis and Clinical Research.

Authors:  Johannes W Dietrich; Gabi Landgrafe-Mende; Evelin Wiora; Apostolos Chatzitomaris; Harald H Klein; John E M Midgley; Rudolf Hoermann
Journal:  Front Endocrinol (Lausanne)       Date:  2016-06-09       Impact factor: 5.555
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.